Events & Presentations

Upcoming Events

There are currently no events to display.

Archives

Date Event Details
Summary Toggle Oct 2 - Oct 3, 2018
Title:  RX-3117, A NOVEL, ORAL NUCLEOSIDE ANALOG, IN COMBINATION WITH NAB-PACLITAXEL (NAB-PAC) IN FIRST-LINE METASTATIC PANCREATIC CANCER (MET-PC): SAFETY, TOLERABILITY AND PRELIMINARY RESPONSES   [View Poster]

Location

National Institutes of Health in Bethesda, Maryland
Summary Toggle Sep 6, 2018
9:35 AM EDT
Sep 6, 2018 9:35 AM EDT 09/06/18
Summary Toggle Jun 1-5, 2018 Jun 1 - Jun 5, 2018 12:00 AM EDT 06/01/18

Title:   Preliminary Results From an Ongoing Phase 2a Study of RX, an Oral Nucleoside Analogue to Treat Advanced Urothelial Cancer (aUC)  [View Poster]

Title:  Preliminary Report of A Phase 1b/2a Trial, An Oral Inhibitor of Phosphorylated P68 (P-p68),  Which Mediates β-catenin Nuclear Translocation in Advanced Triple-Negative Breast Cancer (TNBC)    [View Poster]

Summary Toggle Apr 14-18, 2018 Apr 14, 2018 04/14/18

Title: RX-3117 promotes epigenetic effects in cancer cells through enhanced degradation of DNMT1 [View Poster]

Location

Chicago, Illinois
Summary Toggle Jan 9, 2018
12:00 AM PST
Jan 9, 2018 12:00 AM PST 01/09/18


©2018 by Rexahn Pharmaceuticals, Inc. All rights reserved
Rexahn Pharmaceuticals, Inc. - 15245 Shady Grove Road, Suite 455 - Rockville, MD 20850

Terms of Use
Privacy Policy